Research location

New Brunswick

New Jersey, United States

Published trials708
Site observations784
Linked trials published708
Page1 / 15

Research activity in New Brunswick

New Jersey, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 708 trials and 784 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in New Brunswick

708 linked trials · page 1 of 15
Exercise and Intranasal Insulin in Type 2 DiabetesNCT07675499 · 2026-08-03 · 3 site observations
RECRUITING
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsNCT07330258 · 2026-07-21 · 1 site observation
RECRUITING
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseaseNCT07492641 · 2026-05-22 · 1 site observation
RECRUITING
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerNCT07214532 · 2026-05-08 · 1 site observation
RECRUITING
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsNCT07488676 · 2026-05-04 · 1 site observation
RECRUITING
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPNCT07354074 · 2026-04-28 · 1 site observation
RECRUITING
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin TherapyNCT06814184 · 2026-04-01 · 2 site observations
RECRUITING
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung CancerNCT07057791 · 2026-03-30 · 1 site observation
RECRUITING
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast CancerNCT07402473 · 2026-03-26 · 1 site observation
RECRUITING
The Salt Study for Heart FailureNCT07560592 · 2026-01-21 · 1 site observation
RECRUITING
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerNCT07225946 · 2025-12-19 · 1 site observation
RECRUITING
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)NCT07171684 · 2025-11-26 · 1 site observation
RECRUITING
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerNCT07173751 · 2025-10-30 · 1 site observation
RECRUITING
Metabolic Health, Bones and Nuts During Weight Loss in AdultsNCT06949280 · 2025-10-30 · 1 site observation
RECRUITING
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNCT07100106 · 2025-10-07 · 1 site observation
RECRUITING
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsNCT07165691 · 2025-09-11 · 1 site observation
RECRUITING
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentNCT07158164 · 2025-08-27 · 2 site observations
RECRUITING
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521 · 2025-08-26 · 1 site observation
RECRUITING
Individualizing Treatment for Asthma in Primary Care (Full Study)NCT07052942 · 2025-08-01 · 1 site observation
RECRUITING
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)NCT07060807 · 2025-07-21 · 1 site observation
RECRUITING
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)NCT06966700 · 2025-06-30 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaNCT06977581 · 2025-05-20 · 1 site observation
RECRUITING
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantNCT06563895 · 2025-05-12 · 1 site observation
RECRUITING
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsNCT07080242 · 2025-04-28 · 1 site observation
RECRUITING
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisNCT06408259 · 2025-04-08 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)NCT06686394 · 2025-02-26 · 1 site observation
RECRUITING
Extracellular Vesicles, Insulin Action, and ExerciseNCT06546085 · 2025-02-10 · 3 site observations
RECRUITING
Non-Invasive Preeclampsia Screening and BiobankNCT06643741 · 2025-02-02 · 1 site observation
RECRUITING
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older AdultsNCT07392723 · 2025-01-12 · 1 site observation
RECRUITING
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT06667076 · 2024-12-16 · 1 site observation
RECRUITING
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)NCT06667908 · 2024-12-06 · 1 site observation
RECRUITING
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerNCT05736367 · 2024-11-15 · 2 site observations
RECRUITING
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerNCT06518837 · 2024-10-30 · 1 site observation
RECRUITING
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic PatientsNCT06663813 · 2024-10-29 · 2 site observations
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaNCT06368817 · 2024-10-22 · 2 site observations
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation
RECRUITING
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)NCT06423430 · 2024-09-11 · 1 site observation
RECRUITING
RADIANT: Pre-op Radiation With Abemaciclib and LetrozoleNCT06139107 · 2024-08-22 · 1 site observation
RECRUITING
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerNCT06435429 · 2024-08-13 · 1 site observation
RECRUITING
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerNCT06380751 · 2024-08-01 · 1 site observation
RECRUITING
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyNCT06979323 · 2024-07-19 · 1 site observation
RECRUITING
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyNCT06063850 · 2024-06-12 · 1 site observation
RECRUITING
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)NCT06401421 · 2024-06-07 · 1 site observation
RECRUITING
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)NCT06353386 · 2024-05-20 · 1 site observation
RECRUITING
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and ImmunotherapyNCT06410300 · 2024-04-19 · 1 site observation
RECRUITING
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsNCT05932862 · 2024-04-03 · 1 site observation
RECRUITING
A Phase 1/1b Study of IAM1363 in HER2 CancersNCT06253871 · 2024-03-25 · 1 site observation
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsNCT06112418 · 2024-03-06 · 1 site observation
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.